Why DexCom Surged 23.6% in March
The diabetes management company has launched its latest product to be sold in the United Kingdom.
New tool reveals how immune cells find their targets
Biological engineers have devised a new experimental tool that allows them to precisely pick out interactions between a particular B or T cell and its target antigen.
New tool reveals how immune cells find their targets
Biological engineers have devised a new experimental tool that allows them to precisely pick out interactions between a particular B or T cell and its target antigen.
Why Fastly Stock Was Up While the Market Fell Today
Speculation was floated that a certain internet search giant might be interested in acquiring Fastly.
Why Shiba Inu Is Plummeting Today
The popular cryptocurrency is now down roughly 73% from the high it hit last October.
Here’s Why Bicycle Therapeutics Stock Looks Ill Today
Lackluster clinical trial results for its lead candidate are to blame.
Elon Musk Isn’t Wrong About Twitter Blue
Say what you will about the tumultuous weeklong fling between Twitter and Musk, the provocative billionaire had some good ideas to fix the latter’s flawed subscription program.
Why AT&T Stock Fell Hard Today
Investors exited their positions after AT&T officially sold its media content holdings to Discovery.
Why Tesla Stock Keeps Falling
COVID disrupts Chinese car sales — and Tesla’s Chinese car sales in particular.
3 Top Artificial Intelligence Stocks to Buy Right Now
Nvidia, Salesforce, and Netflix are all great long-term AI plays.
Why Many Semiconductor Stocks Were Down Last Week
Taiwan Semiconductor Manufacturing shared its monthly revenue report.
Why Nio Stock Plunged This Morning
Nio is unable to stick to some of the things it said earlier, and investors aren’t pleased.
Better Buy: Plug Power vs. Bloom Energy
The two fuel cell makers differ significantly in terms of their technologies and target markets.
Understanding ‘smart,’ spitting archerfishes
A new article thoroughly examines the evolutionary history and anatomical variation of archerfishes.
Study suggests why most smokers don’t get lung cancer
Cigarette smoking is overwhelmingly the main cause of lung cancer, yet only a minority of smokers develop the disease. A study suggests that some smokers may have robust mechanisms that protect them from lung cancer by limiting mutations. The findings …
Study suggests why most smokers don’t get lung cancer
Cigarette smoking is overwhelmingly the main cause of lung cancer, yet only a minority of smokers develop the disease. A study suggests that some smokers may have robust mechanisms that protect them from lung cancer by limiting mutations. The findings …
Engineered bacteria could help protect ‘good’ gut microbes from antibiotics
Researchers have engineered a strain of bacteria that can help protect the natural flora of the human digestive tract from antibiotics and curb the emergence of antimicrobial resistance.
Psilocybin rewires the brain for people with depression, study finds
Psilocybin fosters greater connections between different regions of the brain in depressed people, freeing them up from long-held patterns of rumination and excessive self-focus, according to a new study.
Psilocybin rewires the brain for people with depression, study finds
Psilocybin fosters greater connections between different regions of the brain in depressed people, freeing them up from long-held patterns of rumination and excessive self-focus, according to a new study.
Researchers identify a new treatment for metabolic syndrome
Metabolic syndrome increases a person’s risk for diabetes, heart disease, and stroke, and includes conditions such as obesity, high blood pressure and high blood sugar. In a recent mouse-model study researchers have furthered their progress to develop …